CLIA-COLA, Turnkey, Running Lab with Revenue

Novitas MAC – Clean Lab (Medicare-Medicaid billed only from mid-2025) – Metro MD

Investment Highlights
----------------------
✔ Established high-complexity clinical laboratory platform
✔ CLIA-certified and COLA-accredited with all required operating licenses
✔ Comprehensive testing capabilities including:
✔Clinical Chemistry
-Hematology
-Toxicology
-Molecular Diagnostics
-Pharmacogenomics (PGx)
-Microbiology
-Wellness Testing
✔ High-value LC-MS/MS toxicology platform
✔ Molecular diagnostics infrastructure including Real-Time PCR
✔ Existing physician, employer and healthcare organization relationships
✔ Located in a desirable reimbursement jurisdiction with separate Medicare and Medicaid enrollment
✔ Digital laboratory workflow with patient/provider portals and integrated billing
✔ Fully operational laboratory requiring no start-up period

Growth Opportunities
------------------------
The current owner also operates a successful medical practice and has devoted limited time to business development, creating significant upside for an acquirer with established sales relationships. Potential growth initiatives include:
✔Expansion of physician referral network
✔Increased toxicology testing volumes
✔Growth of employer drug testing accounts
✔Expansion of molecular diagnostic services
✔Pharmacogenomic testing
✔Additional payer contracting
✔Geographic expansion
✔Laboratory Infrastructure

The laboratory includes major analytical equipment supporting high-complexity testing, including:
✔LC-MS/MS
✔Clinical Chemistry Analyzer
✔Real-Time PCR Platform
✔Automated DNA Extraction System
✔Estimated replacement value of major equipment: approximately $150K–230K, according to management estimates.

Ideal Buyers
----------------
This opportunity may be attractive to:
✔Existing clinical laboratories seeking a Mid-Atlantic expansion
✔Toxicology laboratories looking for additional capacity
✔Physician-owned laboratories
✔Laboratory entrepreneurs seeking a turnkey platform
✔Healthcare service companies expanding into diagnostics
✔Private investors entering the clinical laboratory industry

Transaction Highlights
---------------------------
✔Turnkey operating laboratory
✔Favorable acquisition price
✔Seller willing to support transition
✔Immediate operating capability
✔Significant organic growth potential
✔Annual revenue for the last 2 years and trending this year at about $400K
✔At Break-Even

Price: $395K



We kindly request that buyers send inquiries using their company email (if you are buying for a company). Also send some background information about yourself and/or your company, along with your LinkedIn profile. This makes sellers more comfortable in sharing their information.